Skip to main content
SpringerLink
Log in

Follikuläre Lymphome in frühen Stadien

MRD als Biomarker für die Prognose und zur Steuerung von Therapieentscheidungen

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Pulsoni A et al. Br J Haematol. 2020;188(2):249-258

  2. Pulsoni A et al. Blood. 2019;134(Supplement_1):124

  3. Pulsoni A et al. Br J Haematol. 2007;137(3):216-20

Download references

Author information

Authors and Affiliations

  1. 2. Medizinische Klinik, Universitätsklinikum Augsburg, Augsburg, Germany

    Patrick Mayr &  Rainer Claus

Authors
  1. Patrick Mayr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rainer Claus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Patrick Mayr or Rainer Claus.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mayr, P., Claus, R. MRD als Biomarker für die Prognose und zur Steuerung von Therapieentscheidungen. InFo Hämatol Onkol 23, 24–26 (2020). https://doi.org/10.1007/s15004-020-8062-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-020-8062-z

Search

Navigation